R Guzmán-Ruiz1, F Ortega2, A Rodríguez3, R Vázquez-Martínez1, A Díaz-Ruiz1, S Garcia-Navarro1, M Giralt4, A Garcia-Rios5, D Cobo-Padilla6, F J Tinahones7, J López-Miranda5, F Villarroya4, G Frühbeck3, J M Fernández-Real2, M M Malagón1. 1. Department of Cell Biology, Physiology and Immunology, Instituto Maimónides de Investigaciones Biomédicas de Córdoba (IMIBIC)/Reina Sofia University Hospital/University of Córdoba, Córdoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Spain. 2. Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomédica de Girona (IdIBGi), Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Spain. 3. Metabolic Research Laboratory, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Spain. 4. Department of Biochemistry and Molecular Biology, Institut de Biomedicina (IBUB), University of Barcelona, Barcelona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Spain. 5. Lipids and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/University of Córdoba, Córdoba, Spain; CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Spain. 6. Bariatric Surgery Unit, Reina Sofia University Hospital, Córdoba, Spain. 7. Biomedical Research Laboratory, Endocrinology and Nutrition Department, Hospital Clinico Virgen de la Victoria, Málaga, Spain; CIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Spain.
Abstract
BACKGROUND: The nuclear protein high-mobility group box 1 (HMGB1) can be passively released by necrotic cells or secreted actively by several cell types to regulate immune and inflammatory responses, as well as tissue remodeling. We herein aimed to characterize the effect of insulin resistance on HMGB1 in adipose tissue and to examine its potential role as a metabolic regulator in β-pancreatic cells. DESIGN: Plasma HMGB1 concentration and adipose HMGB1 expression were assessed in relation to obesity and insulin resistance. Cultured adipocytes from lean and obese patients were used to investigate the intracellular distribution and factors regulating HMGB1 release, as well as to test its effects on adipogenesis and lipid metabolism. A regulatory role for HMGB1 in insulin secretion was also investigated. RESULTS: Circulating HMGB1 was positively associated with body mass index, while adipose HMGB1 mRNA levels correlated with the expression of inflammatory markers. Insulin resistance modified the intracellular distribution of HMGB1 in human adipocytes, with HMGB1 being predominantly nuclear in lean and obese normoglycemic individuals while localized to the cytosol in obese patients with type 2 diabetes. Adipocytes from lean individuals exposed to conditioned media from lipopolysaccharide-stimulated macrophages induced HMGB1 redistribution to the cytoplasm and release. HMGB1 treatment had no effect on differentiation and lipid metabolism in adipocytes. However, HMGB1, whose circulating levels correlated with postload insulin concentration, increased both insulin release and intracellular Ca(2+) concentration in INS-1 cells. CONCLUSIONS: These findings show, for the first time, that HMGB1 expression and release by human adipocytes is altered by inflammatory conditions as those imposed by obesity and insulin resistance. Our data reveal a novel role for HMGB1 as a stimulatory factor of insulin secretion of β-pancreatic cells.
BACKGROUND: The nuclear protein high-mobility group box 1 (HMGB1) can be passively released by necrotic cells or secreted actively by several cell types to regulate immune and inflammatory responses, as well as tissue remodeling. We herein aimed to characterize the effect of insulin resistance on HMGB1 in adipose tissue and to examine its potential role as a metabolic regulator in β-pancreatic cells. DESIGN: Plasma HMGB1 concentration and adipose HMGB1 expression were assessed in relation to obesity and insulin resistance. Cultured adipocytes from lean and obesepatients were used to investigate the intracellular distribution and factors regulating HMGB1 release, as well as to test its effects on adipogenesis and lipid metabolism. A regulatory role for HMGB1 in insulin secretion was also investigated. RESULTS: Circulating HMGB1 was positively associated with body mass index, while adipose HMGB1 mRNA levels correlated with the expression of inflammatory markers. Insulin resistance modified the intracellular distribution of HMGB1 in human adipocytes, with HMGB1 being predominantly nuclear in lean and obese normoglycemic individuals while localized to the cytosol in obesepatients with type 2 diabetes. Adipocytes from lean individuals exposed to conditioned media from lipopolysaccharide-stimulated macrophages induced HMGB1 redistribution to the cytoplasm and release. HMGB1 treatment had no effect on differentiation and lipid metabolism in adipocytes. However, HMGB1, whose circulating levels correlated with postload insulin concentration, increased both insulin release and intracellular Ca(2+) concentration in INS-1 cells. CONCLUSIONS: These findings show, for the first time, that HMGB1 expression and release by human adipocytes is altered by inflammatory conditions as those imposed by obesity and insulin resistance. Our data reveal a novel role for HMGB1 as a stimulatory factor of insulin secretion of β-pancreatic cells.
Authors: S Müller; P Scaffidi; B Degryse; T Bonaldi; L Ronfani; A Agresti; M Beltrame; M E Bianchi Journal: EMBO J Date: 2001-08-15 Impact factor: 11.598
Authors: Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin Journal: J Lipid Res Date: 2005-09-08 Impact factor: 5.922
Authors: B K Rodiño-Janeiro; A Salgado-Somoza; E Teijeira-Fernández; J R González-Juanatey; E Alvarez; S Eiras Journal: Eur J Endocrinol Date: 2011-01-31 Impact factor: 6.664
Authors: Laura Herrero; Hagit Shapiro; Ali Nayer; Jongsoon Lee; Steven E Shoelson Journal: Proc Natl Acad Sci U S A Date: 2009-12-10 Impact factor: 11.205
Authors: José María Moreno-Navarrete; Victoria Catalán; Lauren Whyte; Adenis Díaz-Arteaga; Rafael Vázquez-Martínez; Fernando Rotellar; Rocío Guzmán; Javier Gómez-Ambrosi; Marina R Pulido; Wendy R Russell; Mónica Imbernón; Ruth A Ross; María M Malagón; Carlos Dieguez; José Manuel Fernández-Real; Gema Frühbeck; Ruben Nogueiras Journal: Diabetes Date: 2011-12-16 Impact factor: 9.461
Authors: José María Moreno-Navarrete; Rubén Martínez-Barricarte; Victoria Catalán; Mònica Sabater; Javier Gómez-Ambrosi; Francisco José Ortega; Wifredo Ricart; Mathias Blüher; Gema Frühbeck; Santiago Rodríguez de Cordoba; José Manuel Fernández-Real Journal: Diabetes Date: 2009-10-15 Impact factor: 9.461
Authors: Ashley V Hill; Ramkumar Menon; Maria Perez-Patron; Genny Carrillo; Xiaohui Xu; Brandie D Taylor Journal: Am J Reprod Immunol Date: 2019-07-28 Impact factor: 3.886
Authors: Rajaa El Bekay; Leticia Coín-Aragüez; Diego Fernández-García; Wilfredo Oliva-Olivera; Rosa Bernal-López; Mercedes Clemente-Postigo; Javier Delgado-Lista; Alberto Diaz-Ruiz; Rocío Guzman-Ruiz; Rafael Vázquez-Martínez; Said Lhamyani; María Mar Roca-Rodríguez; Sonia Fernandez Veledo; Joan Vendrell; María M Malagón; Francisco José Tinahones Journal: Br J Pharmacol Date: 2016-04-28 Impact factor: 8.739